Exactech Introduces New Computer-Assisted Software Application for Simplified Guidance in Total Knee Replacement
June 29 2017 - 9:25AM
Business Wire
Surgeon Reports Success with First Case
Using ExactechGPS TKA PLUS
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products and biologic solutions for
extremities, knee and hip, announced the introduction of
ExactechGPS® TKA PLUS, a new software application that provides
orthopaedic surgeons simplified, real-time intraoperative computer
guidance during total knee arthroplasty (TKA). The new application
expands the ExactechGPS portfolio and complements the company’s new
Truliant® Knee System which is also making its clinical debut this
quarter.
Derek Amanatullah, MD, PhD, performed the first surgery using
ExactechGPS TKA PLUS at Stanford University Medical Center. “I was
delighted to experience how seamlessly the system integrated into
my surgical workflow,” he reported. “ExactechGPS TKA PLUS allowed
me to use simple guidance to achieve precision and accuracy in my
cuts, which made the knee replacement case run smoothly. I believe
this system is exactly what surgeons need to help them achieve more
reproducible outcomes.”
ExactechGPS is a computer technology system for guided,
personalized joint replacement surgery. The new TKA PLUS software
application provides surgeons a simple tool to plan, guide and
verify key steps of a knee replacement procedure and easily check
the patient’s implant alignment. This new application expands the
ExactechGPS knee software portfolio, which also includes
comprehensive applications for both primary and revision knee
surgery.
“The launch of TKA PLUS reiterates Exactech’s commitment to
delivering a fully comprehensive knee system to the marketplace,”
said Joseph Pizzurro, vice president of Knee Marketing at Exactech.
“The Truliant system of new implants and instruments, combined with
our ExactechGPS technology, offers orthopaedic surgeons versatility
in managing total knee arthroplasty cases from primary through
revision. We are encouraged by the positive responses we have
received and look forward to continued momentum behind our new knee
system.”
ExactechGPS has been used in more than 8,500 total knee cases in
12 countries across the globe. ExactechGPS TKA PLUS is available in
pilot launch, with full availability expected in 2018.
About ExactechGPS
ExactechGPS combines surgeon expertise with an advanced computer
system to perform the patient’s surgery with a goal of improved
accuracy and precision. Personalized for a patient’s unique bone
structure and anatomy, ExactechGPS is designed to allow surgeons to
decide where to remove bone and place the implant in the optimal
position. Exactech first introduced ExactechGPS to surgeons in the
United States for total knee arthroplasty, and has since broadened
its reach to the shoulder segment. The technology has steadily
gained market acceptance and worldwide reach.
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech can be found
at http://www.exac.com.
A current investment profile on Exactech (Nasdaq: EXAC) is
available online at http://www.hawkassociates.com/profile/exac.cfm.
To receive future releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170629005718/en/
ExactechInvestor contactsJody Phillips, 352-377-1140Executive
Vice President of Finance & Chief Financial OfficerorHawk
AssociatesJulie Marshall or Frank Hawkins,
305-451-1888EXAC@hawkassociates.comorExactechMedia
contactsPriscilla Bennett, 352-377-1140Vice President, Corporate
& Marketing Communication
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Sep 2023 to Sep 2024